Medication Adherence in Korean Patients with Inflammatory Bowel Disease and Its Associated Factors

Objectives: It is important that inflammatory bowel disease (IBD) patients adhere to their prescribed medication regimens to avoid the repeat exacerbations, compli-cations, or surgeries associated with this disorder. However, there are few studies on medication adherence in patients with IBD, especially in Asian populations. So, we analyzed the factors associated with medication adherence in Korean IBD patients.Methods: Patients who had been diagnosed with Crohn's disease (CD) or ulcerative colitis (UC) more than 6 months previously and receiving oral medications for IBD were enrolled. Medication adherence was measured using the Medical Adherence Reporting Scale (MARS-5), a self-reported medication adherence measurement tool.Results: Among 207 patients in the final study population, 125 (60.4%) had CD and 134 (64.7%) were men. The mean age was 39.63 years (SD, 13.16 years) and the mean disease duration was 10.09 years (SD, 6.33 years). The mean medication adherence score was 22.46 (SD, 2.86) out of 25, and 181 (87.4%) patients had score of 20 or higher. In multiple linear regression analysis, self-efficacy (beta=0.341, P<0.001) and >= 3 dosing per day (beta=-0.192 P=0.016) were revealed to be significant factors associated with medication adherence. Additionally, there was a positive correlation between self -ef-ficacy and medication adherence (r=0.312, P<0.001). However, disease related knowl-edge, depression, and anxiety were not significantly associated with medication adherence.Conclusion: To improve medication adherence among patients with IBD, a reduc-tion in the number of doses per day and an improved self-efficacy will be helpful. (Ewha Med J 2022;45(2):35-45)